Clinical evaluation of a commercial ligase-based gene amplification method for detection ofMycobacterium tuberculosis P. AlonsoA. OrduñaA. Rodríguez Torres Article Pages: 371 - 376
Bacteraemia in the adult intensive care unit of a teaching hospital in Nottingham, UK, 1985–1996 M. CroweP. IspahaniR. Winter Article Pages: 377 - 384
Antibiotic resistance inSalmonella enterica serotype typhimurium U. GroßH. TschäpeM. Frosch Note Pages: 385 - 387
Radiometric quantification ofMycobacterium avium complex C. J. HaugP. GaustadF. Müller Note Pages: 388 - 390
Comparison of three media for agar dilution susceptibility testing ofBordetella pertussis using six antibiotics J. E. HoppeT. Paulus Note Pages: 391 - 393
Non-tuberculous mycobacterial infection in children with cancer J. C. GrahamD. A. TweddleS. J. Pedler Note Pages: 394 - 397
In vitro activity of mupirocin against methicillin-resistantStaphylococcus aureus isolated from a hospital in Spain T. AlarcónD. DomingoM. López-Brea Brief Reports Pages: 398 - 399
Urinary tract infection due toArcanobacterium bernardiae in a patient with a urinary tract diversion J. P. LepargneurR. HellerP. Riegel Brief Reports Pages: 399 - 401
Association between quinupristin/dalfopristin resistance in glycopeptide-resistantEnterococcus faecium and the use of additives in animal feed G. WernerI. KlareW. Witte Brief Reports Pages: 401 - 402
Bacteriological activity of trovafloxacin, a new quinolone, against respiratory tract pathogens J. -C. PechèreT. D. Gootz Review Pages: 405 - 412
Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin D. PontaniH. WashtonJ. Johnson Article Pages: 413 - 419
A comparative study on the efficacy of the new quinolone alatrofloxacin in the treatment of experimental Legionellosis in guinea pigs J. García-de-LomasE. MillásS. Sánchez Article Pages: 420 - 423
Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers G. MelnikW. H. SchwesingerJ. Vincent Article Pages: 424 - 426
Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans J. VincentL. DogoloR. Teng Note Pages: 427 - 430
An open, controlled, crossover study on the effects of cimetidine on the steady-state pharmacokinetics of trovafloxacin L. PurkinsS. D. OliverS. A. Willavize Article Pages: 431 - 433
Trovafloxacin versus amoxicillin/clavulanic acid in the treatment of acute exacerbations of chronic obstructive bronchitis P. LéophonteR. J. T. BaldwinN. Pluck Article Pages: 434 - 440
Treatment of acute exacerbations of chronic bronchitis: Comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study B. O'DohertyR. DanielThe Trovafloxacin Bronchitis Study Group Article Pages: 441 - 446
Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia F. TrémolièresF. de KockR. Daniel Article Pages: 447 - 453
Safety of trovafloxacin in treatment of lower respiratory tract infections D. WilliamsS. Hopkins Article Pages: 454 - 458
